The dollar amounts are immaterial relative to MDGL's size, so no immediate bearish read-through. Monitor the next Form 4 filing for any escalation in insider selling volume or pattern, but this cluster alone does not warrant action.
MDGL drugs
MDGL drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 26 $524.28entry
- T+1 · 6mo ago +0.65%α +0.63% · $527.67
- T+5 · 6mo ago −13.62%α −14.84% · $452.86
- T+20 · 5mo ago −0.82%α +1.13% · $520.00
- T+60 · 3mo ago +3.03%α +0.30% · $540.16
Price Chart
How similar events traded
Executive Summary
Two Madrigal insiders (Director Levy and CMO Soergel) sold a combined $456K in open-market transactions, representing approximately 0.004% of MDGL's $11.8B market cap. The amount is trivial and does not convey material bearish signal, consistent with routine portfolio diversification or tax planning.
Key Financial Metrics
Key Facts
- Director Richard S. Levy sold 40 shares at $506.68 on 2026-05-22 for $20,267.
- Chief Medical Officer David Soergel sold 844 shares at $515.90 on 2026-05-18 for $435,420.
- Total cluster value of $456K is less than 0.1% of MDGL's $11.8B market cap.
- Both sales were open-market transactions, not part of a pre-arranged 10b5-1 plan per available data.
Financial Impact
Two insiders sold shares totaling $456K, representing ~0.004% of market cap.
Risk Factors
- No material risk identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MDGL-1779487347673 |
Track record
18 reports on MDGL
3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
- Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
- Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
- Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
- Nov 3, 202613d ago 8-K Bullish 7/10 No price data
- Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
- Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers